DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bn89jc/global_malaria) has announced the addition of the "Global Malaria Pipeline Capsule - 2013" report to their offering.
Fore Pharma's latest report Global Malaria Pipeline Capsule - 2013' provides up-to-date information on key Research and Development (R&D) activities in the global malaria market. It covers active malaria pipeline molecules in clinical trials, preclinical research, and drug discovery.
This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The scope of the report includes information on malaria pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World).
Key Features of the Report:
- Malaria Pipeline Overview
- Malaria Phase 3 Clinical Trial Pipeline
- Malaria Phase 2 Clinical Trial Pipeline
- Malaria Phase 1 Clinical Trial Pipeline
- Malaria Preclinical Research Pipeline
- Malaria Drug Discovery Stage Pipeline
- Malaria Pipeline in the U.S.
- Malaria Pipeline in Europe
- Licensing Activities in Global Malaria Market
For more information visit http://www.researchandmarkets.com/research/bn89jc/global_malaria
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
